Schorr K - Search Results

1

Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissue.

Walter M, Weißbach H, Gembardt F, Halder S, Schorr K, Fleischmann D, Todorov V, Hugo C, Goepferich A. Walter M, et al. Among authors: schorr k. J Drug Target. 2024 Aug 22:1-13. doi: 10.1080/1061186X.2024.2390628. Online ahead of print. J Drug Target. 2024. PMID: 39171543

2

Ectoenzymes as promising cell identification structures for the high avidity targeting of polymeric nanoparticles.

Walter M, Baumann F, Schorr K, Goepferich A. Walter M, et al. Among authors: schorr k. Int J Pharm. 2023 Nov 25;647:123453. doi: 10.1016/j.ijpharm.2023.123453. Epub 2023 Sep 30. Int J Pharm. 2023. PMID: 37783283

3

Rethinking Thin-Layer Chromatography for Screening Technetium-99m Radiolabeled Polymer Nanoparticles.

Schorr K, Chen X, Sasaki T, Arias-Loza AP, Lang J, Higuchi T, Goepferich A. Schorr K, et al. ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2604-2611. doi: 10.1021/acsptsci.4c00383. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296255

4

Towards a Switchable Nanoparticle Behavior Using Inverse Electron-Demand Diels-Alder Chemistry and Ectoenzyme-Based Ligand Activation.

Lang J, Schorr K, Goepferich A. Lang J, et al. Among authors: schorr k. Eur J Pharm Sci. 2024 Oct 24:106944. doi: 10.1016/j.ejps.2024.106944. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 39461601 Free article.

5

A plant-based diet index to study the relation between diet and disease risk among adults: a narrative review.

Schorr KA, Agayn V, de Groot LCPGM, Slagboom PE, Beekman M. Schorr KA, et al. J Nutr Health Aging. 2024 Jun;28(6):100272. doi: 10.1016/j.jnha.2024.100272. Epub 2024 May 29. J Nutr Health Aging. 2024. PMID: 38815475 Free article. Review.

6

Musings on value frameworks in cancer.

Subramanian R, Schorr K. Subramanian R, et al. Among authors: schorr k. J Comp Eff Res. 2016 Aug;5(5):437-9. doi: 10.2217/cer-2016-0041. Epub 2016 Jul 15. J Comp Eff Res. 2016. PMID: 27418104 Free article. No abstract available.

7

Patent watch: Have the biosimilar floodgates been opened in the United States?

Brinckerhoff CC, Schorr K. Brinckerhoff CC, et al. Among authors: schorr k. Nat Rev Drug Discov. 2015 May;14(5):303-4. doi: 10.1038/nrd4622. Nat Rev Drug Discov. 2015. PMID: 25924576 No abstract available.

8

Further sesquiterpene lactones from Viguiera robusta and the potential anti-inflammatory activity of a heliangolide: inhibition of human neutrophil elastase release.

Arakawa NS, Schorr K, Ambrósio SR, Merfort I, Da Costa FB. Arakawa NS, et al. Among authors: schorr k. Z Naturforsch C J Biosci. 2008 Jul-Aug;63(7-8):533-8. doi: 10.1515/znc-2008-7-811. Z Naturforsch C J Biosci. 2008. PMID: 18810997 Free article.

9

Sesquiterpene lactones from Dimerostemma species (Asteraceae) and in vitro potential anti-inflammatory activities.

Stefani R, Schorr K, Tureta JM, Vichnewski W, Merfort I, da Costa FB. Stefani R, et al. Among authors: schorr k. Z Naturforsch C J Biosci. 2006 Sep-Oct;61(9-10):647-52. doi: 10.1515/znc-2006-9-1006. Z Naturforsch C J Biosci. 2006. PMID: 17137108 Free article.

10

Optimisation of a human neutrophil elastase assay and investigation of the effect of sesquiterpene lactones.

Schorr K, Rott A, Da Costa F, Merfort I. Schorr K, et al. Biologicals. 2005 Sep;33(3):175-84. doi: 10.1016/j.biologicals.2005.06.001. Biologicals. 2005. PMID: 16098762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters